Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study

Mostrar otras versiones (1)

PURPOSE: Androgen receptor (AR) expression is absent in 40–90% of estrogen receptor (ER)-negative breast cancers. The prognostic value of AR in ER-negative patients and therapeutic targets for patients absent in AR remains poorly explored. METHODS: We used an RNA-based multigene classifier to identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jinna, Nikita D., Van Alsten, Sarah, Rida, Padmashree, Seewaldt, Victoria L., Troester, Melissa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361868/
https://www.ncbi.nlm.nih.gov/pubmed/37438515
http://dx.doi.org/10.1007/s10549-023-07014-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361868/
https://www.ncbi.nlm.nih.gov/pubmed/37438515
http://dx.doi.org/10.1007/s10549-023-07014-x

Ejemplares similares